US20230135992A1

Combination therapy with a mutant idh inhibitor and a bcl-2 inhibitor

University of Texas System

Abstract

The present invention relates to combination therapy with a mutant IDH inhibitor of Formula (I) and a Bcl-2 inhibitor, for the treatment of cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Nathan Arthur BROOKS
Priority date: March 23, 2020
Filing date: March 22, 2021
Publication date: May 04, 2023
Language: en
PDF source: https://patentimages.storage.googleapis.com/d8/fd/cd/f0e93dce5ac3b1/US20230135992A1.pdf
Metadata fetched: August 29, 2026 00:30